convalescent plasma treatment living meta-analysis of clinical studies

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only

	COVID 19 all comers	COVID-19 mild to moderate	COVID-19 severe or critically

	COVID 19 hospitalized	COVID 19 all comers	COVID-19 mild to moderate	COVID-19 severe or critically
convalescent plasma treatment	CONCOR-1 COPLA-II trial CONFIDENT Salman Baldeon ConPlas-19 CPC-SARS NCT04403477 ... Kirenga Menichetti COP-COVID-19 LACCPT ConCOVID ... CONTAIN COVID-19 NCT04442191 ASCOT PERUCONPLASMA Co-CLARITY RECOVERY ... NCT04528368 PC/COVID-19 DAWN-Plasma Bennett-Guerrero Holm K NCT04397757 NCT04385199 CCAP-2 PLACO-COVID	LIFESAVER	PLACID Libster	Li AlQahtani PICP19 ... Rasheed O’Donnell PlasmAr CP-COVID-19 REMAP-CAP ... Pouladzadeh ILBS-COVID-02 ... CAPSID RECOVER Sekine ... Ray

5406	Duan, 2020	1	13	4		not a RCT	high risk of bias
5446	Sean, 2020	1	13	4		not a RCT	high risk of bias
5549	Hegerova, 2020	1	13	4		not a RCT	high risk of bias
5550	Abolghasemi, 2020	1	13	4		not a RCT	high risk of bias
5569	Dai W, 2020	2	13	4	excluded	not a RCT	high risk of bias
5662	Salazar, 2020	1	13	4		not a RCT	high risk of bias
5761	Joyner, 2020	1	31	3		not a RCT	high risk of bias
6159	Gemici, 2020	0	13	0	selection pending
6940	Bihariesingh-Sanchit (SuriCovid), 2021	1	31	0		not a RCT	risk of bias not avaialble